Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Ralph Lauren Corp (RL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Ralph Lauren Corp — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while Ralph Lauren Corp trades at $377.26 (market cap $22.36B). The key difference: Ralph Lauren Corp is far larger — about 2.6× Hinge Health Inc. Class A Common Stock's market cap, and Ralph Lauren Corp pays a 1.07% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Ralph Lauren Corp for 84 Days on average.
| HNGE | RL | |
|---|---|---|
Market Cap | $8.47B | $22.36B |
Volume | 1,624,526 | 502,434 |
Sector | Health | Consumer Cyclical |
52-Week High | $105.14 | $414.25 |
52-Week Low | $31.17 | $309.29 |
Typical Hold Time | 0 Days | 84 Days |
Enterprise Value | $8.09B | $23.42B |
Dividend Yield | — | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Ralph Lauren (RL) trades at $373.75, up 0.14% on the day, with a bullish technical signal from moving averages and strong analyst support. The company shows robust fundamentals with revenue growth from $7.08B in 2025 to projected $8.4B in 2026, net income margin improving to 11.76%, and consistent earnings beats. Recent news highlights expansion efforts, AI integration, and a declared dividend, reinforcing positive momentum.
The outlook is favorable given earnings growth, luxury brand strength, and a consensus price target of $456.67 implying 22% upside. Risks include market volatility, competitive pressures, and execution of global strategies. Analyst sentiment is strongly bullish with 66.7% buy ratings, supporting a constructive view for investors seeking exposure to a growing apparel leader.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Ralph Lauren Corp
Founded by designer Ralph Lauren in 1967, Ralph Lauren Corp. designs, markets, and distributes lifestyle products in North America, Europe, and Asia. Its products include apparel, footwear, eyewear, jewelry, leather goods, home products, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, Lauren Ralph Lauren, and Double RL. Distribution channels for Ralph Lauren include wholesale (including department stores and specialty stores), retail (including company-owned retail stores and e-commerce), and licensing.
Read more on RL →
